Clinical Trial Update: Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study

View source ↗

Summary

Update on the completed INCEPTA ICD/CRT-D study with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sudden Cardiac Death

Snippet

Sponsor: Guidant Corporation | Conditions: Sudden Cardiac Death, Heart Failure | Status: COMPLETED | Results posted: 2014-04-08